Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial.

[1]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[2]  B. Davis,et al.  Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial , 2002, Circulation.

[3]  S. Borzak,et al.  Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. , 2002, American heart journal.

[4]  R. Wolfe,et al.  Cardiovascular mortality in children and young adults with end-stage kidney disease. , 2002, The Journal of pediatrics.

[5]  R. Califf,et al.  Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation , 2002, Circulation.

[6]  M. Bell,et al.  The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. , 2002, Journal of the American College of Cardiology.

[7]  N. Weissman,et al.  Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. , 2002, The American journal of cardiology.

[8]  B. Usher,et al.  Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  G. Helft,et al.  Clinical outcome following coronary angioplasty in dialysis patients: a case–control study in the era of coronary stenting , 2001, Heart.

[10]  I. Palacios,et al.  Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era? , 2000, Circulation.

[11]  D. Baim,et al.  Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. , 2000, The American journal of cardiology.

[12]  P. Fitzgerald,et al.  The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. , 2000, American heart journal.

[13]  D. Levy,et al.  Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. , 1999, Archives of internal medicine.

[14]  C. Herzog.  Acute myocardial infarction in patients with end-stage renal disease. , 1999, Kidney international. Supplement.

[15]  B. Kasiske,et al.  Excerpts from the United States Renal Data System 1998 Annual Data Report. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  K. Ivens,et al.  Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography , 1997, Heart.

[17]  S. Takeshita,et al.  Percutaneous transluminal coronary angioplasty for chronic dialysis patients. , 1993, The Journal of invasive cardiology.

[18]  Brunner Fp,et al.  Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. , 1992 .

[19]  F. Brunner,et al.  Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. , 1992, Kidney international. Supplement.

[20]  B. Rutherford,et al.  Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. , 1990, American heart journal.

[21]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[22]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.